|
|
Article: Start Licensing Grants License Rights to GTC Biotherapeutics.(GTC Biotherapeutics Inc.)
- Article from:
- BIOTECH Patent News
- Article date:
- April 1, 2007
CopyrightCOPYRIGHT 2007 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Start Licensing, Inc. (Austin, TX) announced that it has granted GTC Biotherapeutics, Inc. a non-exclusive license to Roslin Institute patents and patent applications. These applications include the foundational somatic cell nuclear transfer cloning technology developed at the Roslin Institute for cloning Dolly the sheep. The license agreement allows GTC use of nuclear transfer cloning techniques to generate transgenic animals that produce therapeutic proteins in their milk.
In exchange for the license rights, GTC paid a combined upfront fee of $500,000 in cash and stock, including $200,000 in cash to Start and $300,000 in shares of GTC stock split equally ...